Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Top 3 Hospital Stocks Well Positioned for Healthcare Reform: HCA Holdings Inc (HCA) and More

Page 1 of 2

The healthcare reform law aims to expand insurance coverage to roughly 30 million uninsured Americans. The Affordable Care Act will provide millions of Americans with access to healthcare, creating new revenue streams for companies across the sector. The Act requires every American to acquire health insurance by 2014 or be subjected to a tax. Those who can’t afford health insurance will be offered subsidies or Medicaid. With more patients becoming eligible for Medicare and Medicaid coverage, hospitals are expected to see a reduction in bad debt expenses as more patients will be able to pay for their care.

Total healthcare spending is projected to grow from an estimated $2.8 trillion last year to $4.8 trillion by 2021, an increase of 70%. As a result, the stocks of private hospital operating companies are expected to outperform the S&P 500 index by a significant margin. I think this is the right time to pick up some fundamentally solid stocks in the sector.

I’ve screened three stocks based on one key metric, EBITDA Margin, which essentially measures the operating profit that a company is able wring out of each dollar of sales. The stocks I favor should have at least 12% EBITDA Margin consistently for the past four quarters, which ensures they are well positioned to benefit from the healthcare reform in 2014. I hope you will find the stocks listed below rather interesting.

My top pick based on EBITDA Margin is HCA Holdings Inc (NYSE:HCA), which is one of the largest private operators of health care facilities in the world. It is based in Nashville, Tennessee and currently manages 163 hospitals comprised of 157 general and acute care hospitals, 5 psychiatric hospitals, and 1 rehabilitation hospital. In addition, it operates 112 freestanding surgery centers. Its operations are structured into three geographically organized groups: National, Southwest, and Central.

Barclays Capital assigns it an “overweight” rating in an industry on which it has a neutral assessment overall. Jefferies Group raised their price target on shares of HCA Holdings from $30.00 to $45.00. They now have a “buy” rating on the stock. Deutsche Bank also raised their price target on HCA Holdings from $40.00 to $44.00 with a “buy” rating.

HCA’s strong margins have translated into spectacular FCF (free cash flow) growth. Strong FCF should help to inoculate HCA against a difficult operating environment for the industry.

Health Management Associates Inc (NYSE:HMA)HCA Holdings released its latest earnings data recently. The company reported $0.92 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.83 by $0.09. The company had revenue of $8.43 billion for the quarter, compared to the consensus estimate of $8.95 billion. During the same quarter in the previous year, the company posted $0.94 earnings per share. The company’s revenue for the quarter was up 13.2% on a year-over-year basis. The company has set its FY13 guidance at $3.00-3.30 EPS. Analysts expect that the company will post $3.63 EPS for the current fiscal year.

EBITDA Margin TTM data by YCharts

The no. 2 pick is Health Management Associates, Inc. (NYSE:HMA), which is a company that operates hospitals and health care facilities in the southern United States and is spreading across 15 states, with more than 10,000 physicians on staff. Health Management presently touches more than 3.5 million lives a year, and continues to grow.

Health Management reported 3rd quarter 2012 earnings of $0.18 per share. The company also had revenues of $1.7 billion. This beat the $1.6 billion consensus of the 14 analysts covering the company, and was 18.8% above the prior year’s 3rd quarter results.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!